SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Dauntless who wrote (2786)3/17/1998 12:48:00 PM
From: Linda Kaplan  Read Replies (2) of 7041
 
Dauntless,

Okay, peace... except I still have a few quibbles. Your saying "long a competitor" puts Zonagen on an equal plane with Vivus. Zonagen isn't a competitor until it has an approved product. Pfizer might have an almost approved product, so they might be considered a competitor to Vivus, but Zonagen isn't there yet.

Collaborative seems like a wrong word, too, suggesting an active partnership between the two companies. Perhaps one would enhance the market for the other, but that's really not a collaboration, is it?

Linda
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext